Insider · CIK 0001739816
Peter E. Boyd
Files at AQST (Aquestive Therapeutics, Inc.). First filing Sep 8, 2025, latest Sep 29, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AQST: Aquestive Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 11Weak | Aquestive Therapeutics, Inc. | $63k 10,000 shares | -3% | +170% from low0% from high | |
| 19Weak | Aquestive Therapeutics, Inc. | $80k 15,000 shares | -5% | +144% from low-4% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | AQST Aquestive Therapeutics, Inc. | XIn-the-money exercise Common Stock | +2,293 | $0.96 | $2,201 | 284,024 | 32 d ago |
| Sep 9, 2026 | AQST Aquestive Therapeutics, Inc. | XIn-the-money exercise Warrant (Right to Buy)derivative | -2,293 | $0.00 | $0 | 0 | 32 d ago |
| Sep 26, 2025 | AQST Aquestive Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -10,000 | $6.30 | $63k | 278,323 | Sep 29, 2025 |
| Sep 5, 2025 | AQST Aquestive Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -15,000 | $5.30 | $80k | 288,323 | Sep 8, 2025 |
| Mar 7, 2025 | AQST Aquestive Therapeutics, Inc. | AGrant or award Common Stock | +80,000 | $0.00 | $0 | 317,628 | Mar 11, 2025 |
| Mar 7, 2025 | AQST Aquestive Therapeutics, Inc. | FTax withholding Common Stock | -6,624 | $2.65 | $18k | 311,004 | Mar 11, 2025 |
| Mar 9, 2025 | AQST Aquestive Therapeutics, Inc. | FTax withholding Common Stock | -7,681 | $2.65 | $20k | 303,323 | Mar 11, 2025 |
| Mar 7, 2025 | AQST Aquestive Therapeutics, Inc. | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Mar 11, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.